193 related articles for article (PubMed ID: 15581023)
1. Molecular abnormalities in pediatric embryonal brain tumors--analysis of loss of heterozygosity on chromosomes 1, 5, 9, 10, 11, 16, 17 and 22.
Zakrzewska M; Rieske P; Debiec-Rychter M; Zakrzewski K; Polis L; Fiks T; Liberski PP
Clin Neuropathol; 2004; 23(5):209-17. PubMed ID: 15581023
[TBL] [Abstract][Full Text] [Related]
2. Detection of genetic and chromosomal aberrations in medulloblastomas and primitive neuroectodermal tumors with DNA microarrays.
Kagawa N; Maruno M; Suzuki T; Hashiba T; Hashimoto N; Izumoto S; Yoshimine T
Brain Tumor Pathol; 2006 Apr; 23(1):41-7. PubMed ID: 18095118
[TBL] [Abstract][Full Text] [Related]
3. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
Denzinger S; Mohren K; Knuechel R; Wild PJ; Burger M; Wieland WF; Hartmann A; Stoehr R
Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913
[TBL] [Abstract][Full Text] [Related]
4. Combined genome-wide allelotyping and copy number analysis identify frequent genetic losses without copy number reduction in medulloblastoma.
Langdon JA; Lamont JM; Scott DK; Dyer S; Prebble E; Bown N; Grundy RG; Ellison DW; Clifford SC
Genes Chromosomes Cancer; 2006 Jan; 45(1):47-60. PubMed ID: 16149064
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors.
Biegel JA; Burk CD; Barr FG; Emanuel BS
Cancer Res; 1992 Jun; 52(12):3391-5. PubMed ID: 1596898
[TBL] [Abstract][Full Text] [Related]
6. Imbalances of chromosome arm 1p in pediatric and adult germ cell tumors are caused by true allelic loss: a combined comparative genomic hybridization and microsatellite analysis.
Zahn S; Sievers S; Alemazkour K; Orb S; Harms D; Schulz WA; Calaminus G; Göbel U; Schneider DT
Genes Chromosomes Cancer; 2006 Nov; 45(11):995-1006. PubMed ID: 16897744
[TBL] [Abstract][Full Text] [Related]
7. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity on 6q, 16q, and 17p in human central nervous system primitive neuroectodermal tumors.
Thomas GA; Raffel C
Cancer Res; 1991 Jan; 51(2):639-43. PubMed ID: 1670763
[TBL] [Abstract][Full Text] [Related]
9. Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping.
Bayani J; Zielenska M; Marrano P; Kwan Ng Y; Taylor MD; Jay V; Rutka JT; Squire JA
J Neurosurg; 2000 Sep; 93(3):437-48. PubMed ID: 10969942
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic evaluation of isochromosome 17q in posterior fossa tumors of children and correlation with clinical outcome in medulloblastoma. Detection of a novel chromosomal abnormality.
DeChiara C; Borghese A; Fiorillo A; Genesio R; Conti A; D'Amore R; Pettinato G; Varone A; Maggi G
Childs Nerv Syst; 2002 Aug; 18(8):380-4. PubMed ID: 12192498
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions.
Daido S; Takao S; Tamiya T; Ono Y; Terada K; Ito S; Ouchida M; Date I; Ohmoto T; Shimizu K
Oncol Rep; 2004 Oct; 12(4):789-95. PubMed ID: 15375501
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetic studies in medulloblastomas: evidence for tumor suppressor genes at the chromosomal regions 1q31-32 and 17p13.
Pietsch T; Koch A; Wiestler OD
Klin Padiatr; 1997; 209(4):150-5. PubMed ID: 9293446
[TBL] [Abstract][Full Text] [Related]
13. No evidence for mutations or altered expression of the Suppressor of Fused gene (SUFU) in primitive neuroectodermal tumours.
Koch A; Waha A; Hartmann W; Milde U; Goodyer CG; Sörensen N; Berthold F; Digon-Söntgerath B; Krätzschmar J; Wiestler OD; Pietsch T
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):532-9. PubMed ID: 15488029
[TBL] [Abstract][Full Text] [Related]
14. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.
Gorringe KL; Ramakrishna M; Williams LH; Sridhar A; Boyle SE; Bearfoot JL; Li J; Anglesio MS; Campbell IG
Genes Chromosomes Cancer; 2009 Oct; 48(10):931-42. PubMed ID: 19603523
[TBL] [Abstract][Full Text] [Related]
15. Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort.
Pollack IF; Hamilton RL; James CD; Finkelstein SD; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL;
J Neurosurg; 2006 Nov; 105(5 Suppl):418-24. PubMed ID: 17328268
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathogenesis of pediatric astrocytic tumors.
Nakamura M; Shimada K; Ishida E; Higuchi T; Nakase H; Sakaki T; Konishi N
Neuro Oncol; 2007 Apr; 9(2):113-23. PubMed ID: 17327574
[TBL] [Abstract][Full Text] [Related]
17. Chromosome abnormalities of eighty-one pediatric germ cell tumors: sex-, age-, site-, and histopathology-related differences--a Children's Cancer Group study.
Bussey KJ; Lawce HJ; Olson SB; Arthur DC; Kalousek DK; Krailo M; Giller R; Heifetz S; Womer R; Magenis RE
Genes Chromosomes Cancer; 1999 Jun; 25(2):134-46. PubMed ID: 10337997
[TBL] [Abstract][Full Text] [Related]
18. Chromosome abnormalities in pediatric brain tumors.
Griffin CA; Hawkins AL; Packer RJ; Rorke LB; Emanuel BS
Cancer Res; 1988 Jan; 48(1):175-80. PubMed ID: 3334992
[TBL] [Abstract][Full Text] [Related]
19. Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization.
Reardon DA; Michalkiewicz E; Boyett JM; Sublett JE; Entrekin RE; Ragsdale ST; Valentine MB; Behm FG; Li H; Heideman RL; Kun LE; Shapiro DN; Look AT
Cancer Res; 1997 Sep; 57(18):4042-7. PubMed ID: 9307291
[TBL] [Abstract][Full Text] [Related]
20. A role for fluorescence in situ hybridization detection of chromosome 22q dosage in distinguishing atypical teratoid/rhabdoid tumors from medulloblastoma/central primitive neuroectodermal tumors.
Bruch LA; Hill DA; Cai DX; Levy BK; Dehner LP; Perry A
Hum Pathol; 2001 Feb; 32(2):156-62. PubMed ID: 11230702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
